Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Wave Life Sci Ord Sh (NQ: WVE ) 6.230 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Jun 14, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open 6.230 Bid (Size) 2.500 (2) Ask (Size) 6.880 (2) Prev. Close 6.230 Today's Range 6.230 - 6.230 52wk Range 3.450 - 7.670 Shares Outstanding 98,983,261 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Wave Life Sciences Announces Upcoming Presentations Highlighting Novel siRNA Program in Obesity and Leadership in RNA Editing June 12, 2024 From Wave Life Sciences USA, Inc. Via GlobeNewswire Wave Life Sciences to Present at 2024 Jefferies Global Healthcare Conference May 30, 2024 From Wave Life Sciences USA, Inc. Via GlobeNewswire Performance YTD +16.67% +16.67% 1 Month -0.48% -0.48% 3 Month +9.88% +9.88% 6 Month +38.75% +38.75% 1 Year +48.33% +48.33% More News Read More WAVE Life Sciences Stock: A Deep Dive Into Analyst Perspectives (5 Ratings) May 15, 2024 Via Benzinga WVE Stock Earnings: WAVE Life Sciences Misses EPS, Misses Revenue for Q1 2024 May 09, 2024 Via InvestorPlace WAVE Life Sciences's Earnings Outlook March 05, 2024 Via Benzinga Wave Life Sciences Reports First Quarter 2024 Financial Results and Provides Business Update May 09, 2024 From Wave Life Sciences USA, Inc. Via GlobeNewswire Wave Life Sciences Announces Appointment of Dr. Erik Ingelsson as Chief Scientific Officer May 09, 2024 From Wave Life Sciences USA, Inc. Via GlobeNewswire Wave Life Sciences to Present at 2024 RBC Capital Markets Global Healthcare Conference May 07, 2024 From Wave Life Sciences USA, Inc. Via GlobeNewswire Wave Life Sciences First Quarter 2024 Financial Results Scheduled for May 9, 2024 May 02, 2024 From Wave Life Sciences USA, Inc. Via GlobeNewswire Wave Life Sciences Announces Approval of First Clinical Trial Application for RestorAATion-2 Trial of WVE-006 in Individuals with Alpha-1 Antitrypsin Deficiency (AATD) April 30, 2024 From Wave Life Sciences USA, Inc. Via GlobeNewswire Wave Life Sciences Announces Continued Momentum in GSK Collaboration and Advancements in siRNA and RNA Editing April 23, 2024 From Wave Life Sciences USA, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Thursday's After-Market Session April 04, 2024 Via Benzinga Wave Life Sciences to Present at Upcoming Investor Conferences March 27, 2024 From Wave Life Sciences USA, Inc. Via GlobeNewswire American Eagle Reports Upbeat Earnings, Joins Kroger, Burlington Stores And Other Big Stocks Moving Higher On Thursday March 07, 2024 Via Benzinga Topics Stocks Exposures US Equities Why HighPeak Energy Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session March 07, 2024 Via Benzinga WVE Stock Earnings: WAVE Life Sciences Beats EPS, Beats Revenue for Q4 2023 March 06, 2024 Via InvestorPlace Box Reports Upbeat Earnings, Joins American Public Education, Wave Life Sciences And Other Big Stocks Moving Higher On Wednesday March 06, 2024 Via Benzinga Topics Stocks Exposures US Equities Why United Natural Foods Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session March 06, 2024 Via Benzinga Wave Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update March 06, 2024 From Wave Life Sciences USA, Inc. Via GlobeNewswire Earnings Scheduled For March 6, 2024 March 06, 2024 Via Benzinga Wave Life Sciences Fourth Quarter and Full Year 2023 Financial Results Scheduled for March 6, 2024 February 28, 2024 From Wave Life Sciences USA, Inc. Via GlobeNewswire Wave Life Sciences Announces Upcoming Presentations at MDA Conference that Highlight Best-in-Class Potential for WVE-N531 in Duchenne Muscular Dystrophy February 27, 2024 From Wave Life Sciences USA, Inc. Via GlobeNewswire $16.5M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying January 31, 2024 Via Benzinga Sarepta Therapeutics Inc.: Why it's a rising gene therapy star January 23, 2024 Via MarketBeat Wave Life Sciences Highlights Recent Achievements and Upcoming 2024 Milestones January 08, 2024 From Wave Life Sciences USA, Inc. Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
